Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with bestatin
- 1 January 1984
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 6 (2), 87-92
- https://doi.org/10.1016/0192-0561(84)90001-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Mechanism of T Cell Activation: Role and Functional Relationship of HLA‐DR Antigens and InterleukinsImmunological Reviews, 1982
- Studies of cultured human T lymphocytes. I. Production of the T cell growth-promoting lymphokine interleukin-2Journal of Immunological Methods, 1982
- T‐Cell Growth FactorImmunological Reviews, 1980
- Bestatin, a new immunomodulator. In vivo and n vitro studies in manInternational Journal of Immunopharmacology, 1980
- T‐CELL GROWTH FACTOR‐MEDIATED T‐CELL PROLIFERATION*Annals of the New York Academy of Sciences, 1979
- Aminopeptidase activities on the surface of mammalian cellsBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.The Journal of Antibiotics, 1976
- The structure of bestatin.The Journal of Antibiotics, 1976
- Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of aminopeptidase B and leucine aminopeptidase.The Journal of Antibiotics, 1976